May 1, 2017

Edixomed completes anti-microbial efficacy study An independent analysis performed by Perfectus Biomed and utilising the FDA stipulated AATCC Test Method 100-2004, indicates that the Company’s lead product has achieved the required bacterial and fungal reduction to support claiming “antimicrobial effectiveness” in both antibiotic sensitive and resistant organisms.

30 TECHNOLOGY is developing and defining new models of care to treat many serious medical conditions by enhancing the body’s healing and defence mechanisms.

30 TECHNOLOGY Therapeutic Nitric Oxide